Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

3

Efficacy of 48-week clevudine therapy for chronic hepatitis B

Min Hwan Kim, M.D., Kyung-Ah Kim, M.D., June Sung Lee, M.D., Hyun Woong Lee, M.D. Hyung Joon Kim, M.D. Sang Gu Yun, M.D., Nam-Hoon Kim, M.D., Won Ki Bae, M.D., Young Soo Moon, M.D.

Clin Mol Hepatol. 2009;15(3):331-337. Published online September 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.3.331

View: 4872 Download: 23 Crossref: 8

Long-term clevudine therapy in nucleos(t)ide-naive and Lamivudine-experienced patients with hepatitis B virus-related chronic Liver diseases

Heon Ju Lee, M.D., Jong Ryul Eun, M.D., Chang Hyeong Lee, M.D. Jae Seok Hwang, M.D. Jeong Ill Suh, M.D. Byung Seok Kim, M.D. Byoung Kuk Jang, M.D. Departments of

Clin Mol Hepatol. 2009;15(2):179-192. Published online June 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.2.179

View: 5670 Download: 32 Crossref: 12

Comparison of Lamivudine-induced HBsAg Loss rate according to age in children with chronic hepatitis B

Jung Mi Kim , Byung Ho Choe , Mi Ae Chu , Seung Man Cho

Clin Mol Hepatol. 2009;15(2):168-178. Published online June 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.2.168

View: 4459 Download: 44 Crossref: 3

Distribution of hepatitis B virus genotypes in Korea

Ji-Hyun Cho, M.D. Kui-Hyun Yoon, M.D. Key-Earn Lee, M.D. Do-Sim Park, M.D. Young-Jin Lee, M.D. Hyung-Bae Moon, M.D. Kyoung R. Lee, M.D. Chang-Soo Choi, M.D. Eun-Young Cho, M.D. Haak-Cheoul Kim, M.D.

Clin Mol Hepatol. 2009;15(2):140-147. Published online June 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.2.140

View: 5305 Download: 51 Crossref: 40

Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation

Seong Yong Woo , Se Hyun Cho , Se Min Lee , Myoung Beom Koh , Chee Ho Noh , Chang Wook Kim , Jong Young Choi , Jin Mo Yang , Joon Yeol Han , Young Sok Lee

Clin Mol Hepatol. 2009;15(2):131-139. Published online June 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.2.131

View: 4491 Download: 32 Crossref: 2

1

Clevudine therapy in patients with chronic hepatitis B

Kwan Sik Lee

Clin Mol Hepatol. 2009;15(2):119-121. Published online June 30, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.2.119

View: 4154 Download: 22 Crossref: 2

3

Analysis of the cost-effectiveness of antiviral therapies in chronic hepatitis B patients in Korea

Byung Kook Kim, M.D., So Young Kwon, M.D., Chang Hong Lee, M.D., Won Hyeok Choe, M.D., Hong Mi Choi, M.S. Hye Won Koo, M.D.

Clin Mol Hepatol. 2009;15(1):25-41. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.25

View: 5284 Download: 55 Crossref: 3

Inhibition of in vitro hepatitis B virus replication by Lentivirus-mediated short-hairpin RNA against HBx

Jin Wook Kim , Sang Hyub Lee , Young Soo Park , Sook Hyang Jeong , Na Young Kim , Dong Ho Lee

Clin Mol Hepatol. 2009;15(1):15-24. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.15

View: 5014 Download: 58 Crossref: 6

2

Genetic epidemiological study on single nucleotide polymorphisms associated with hepatocellular carcinoma in patients with chronic HBV infection

Yoon Jun Kim , Hyo Suk Lee

Clin Mol Hepatol. 2009;15(1):7-14. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.7

View: 5464 Download: 40 Crossref: 3

1

Inhibition of hepatitis B virus replication by RNA interference

Yun Gyu Park

Clin Mol Hepatol. 2009;15(1):1-6. Published online March 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.1.1

View: 4304 Download: 32

4

A case report of treatment with pegylated interferon alpha for Lamivudine-resistant chronic hepatitis B virus infection

Won Haing Hur , Hyun Young Woo , Soung Won Jeong , Chan Ran You , Si Hyun Bae , Jong Young Choi , Seung Kew Yoon

Clin Mol Hepatol. 2008;14(4):513-518. Published online December 31, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.4.513

View: 4723 Download: 30 Crossref: 1

3

The efficacy of adefovir dipivoxil monotherapy and the incidence of genotypic resistance to adefovir dipivoxil in patients with Lamivudine-resistant chronic hepatitis B infection

Jae Hyeon Moon , Mong Cho , Ki Tae Yoon , Jung Ho Bae , Jeong Heo , Gwang Ha Kim , Dae Hwan Kang , Geun Am Song

Clin Mol Hepatol. 2008;14(4):503-512. Published online December 31, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.4.503

View: 4264 Download: 16 Crossref: 2

2

Hepatitis B virus genetic diversity and mutant

Hyung Joon Yim

Clin Mol Hepatol. 2008;14(4):446-464. Published online December 31, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.4.446

View: 6660 Download: 145 Crossref: 9

7

The Korean Journal of Entecavir 1 mg therapy for Lamivudine-refractory chronic hepatitis B

Hyung Joon Kim

Clin Mol Hepatol. 2008;14(3):411-416. Published online September 30, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.3.411

View: 4034 Download: 15

The Korean Journal of Adefovir plus Lamivudine combination therapy in Lamivudine-resistant chronic hepatitis B

So Young Kwon

Clin Mol Hepatol. 2008;14(2):235-239. Published online June 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.2.235

View: 3648 Download: 20

4

Hepatitis B virus reactivation during chlorambucil and prednisolone treatment in an HBsAg-negative and anti-HBs-positive patient with B-cell chronic Lymphocytic Leukemia

Suang Min Lim , Jeong Won Jang , Byung Wook Kim , Hwang Choi , Kyu Yong Choi , Soo Jeong Park , Chi Wha Han

Clin Mol Hepatol. 2008;14(2):213-218. Published online June 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.2.213

View: 4673 Download: 47 Crossref: 6

7

The Korean Journal of Normal range of serum ALT level in patients with chronic hepatitis

Yeon Seok Seo

Clin Mol Hepatol. 2008;14(1):116-121. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.116

View: 4258 Download: 18

3

Factors affecting initial virologic response and emergence of resistant mutants after adefovir treatment in lamivudine-resistant chronic hepatitis B patients

Jin Hee Cho, M.D., Jae Youn Cheong, M.D., Joon Koo Kang, M.D., Jin Sun Park, M.D., Myoung Hee Lee, M.D., Nam Kyu Lim, M.D., Sun Pyo Hong. Soo-Ok Kim. Wang Don Yoo. and Sung Won Cho, M.D.

Clin Mol Hepatol. 2008;14(1):58-66. Published online March 20, 2008

DOI: https://doi.org/10.3350/kjhep.2008.14.1.58

View: 4499 Download: 22 Crossref: 1

Change of HBV DNA Level as a Predictor of HBeAg Loss after Lamivudine Treatment

Jae Kwon Jung, M.D., Chang Hyeong Lee, M.D., Eun Young Kim, M.D., Jin Tae Jung, M.D., Joon Hyuck Choi, M.D., Ji Min Han, M.D., Myoung In Jin, M.D., Ju Yeon Cho, M.D., Byung Seok Kim, M.D., Im Hee Shin, Ph.D.

Clin Mol Hepatol. 2007;13(4):513-520. Published online December 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.4.513

View: 3717 Download: 28

The Efficacy and Safety of Telbivudine in Korean Patients with Chronic Hepatitis B

Young-Myoung Moon, M.D. Seong-Gyu Hwang, M.D. Boo-Sung Kim, M.D. Kyu-Sung Rim, M.D. Mong Cho, M.D. Dong-Joon Kim, M.D. Joon-Yeol Han, M.D. Young-Seok Kim, M.D. Ho-Soon Choi, M.D. Sang-Hoon Ahn, M.D.

Clin Mol Hepatol. 2007;13(4):503-512. Published online December 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.4.503

View: 4570 Download: 29 Crossref: 6

Effect of Initial Virologic Response to Adefovir on the Development of Resistance to Adefovir in Lamivudine-resistant Chronic Hepatitis B

In Hee Kim , Seong Hun Kim , Hyun Chul Kim , Kyoung Deok Shin , Sang Wook Kim , Seong Ok Lee , Soo Teik Lee , Dae Ghon Kim

Clin Mol Hepatol. 2007;13(3):349-362. Published online September 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.3.349

View: 4124 Download: 18 Crossref: 1

2

Molecular Mechanisms of Hepatitis B Virus-associated Hepatocellular Carcinoma

Neung Hwa Park, M.D., Young-Hwa Chung, M.D.

Clin Mol Hepatol. 2007;13(3):320-340. Published online September 20, 2007

DOI: https://doi.org/10.3350/kjhep.2007.13.3.320

View: 6360 Download: 94 Crossref: 11

3

Predictors of Lamivudine Resistance in Patients with Chronic Hepatitis B Virus Infection

Jeong Heo , Mong Cho , Byung Mann Cho , Sun Mi Lee , Tae Oh Kim , Gwang Ha Kim , Dae Hwan Kang , Geun Am Song

Clin Mol Hepatol. 2007;13(2):157-165. Published online January 1, 1970

View: 2784 Download: 15

Clinical Outcomes of Lamivudine Therapy in HBeAg Positive Chronic Hepatitis B with Minimally Elevated ALT

Dong Ha Han , Neung Hwa Park , Jung Woo Shin , Seok Won Jung , Young Tae Hwang , Hyun Soo Kim , In Du Jeong , Sung Jo Bang , Do Ha Kim

Clin Mol Hepatol. 2007;13(2):146-156. Published online January 1, 1970

View: 2807 Download: 20

7

The Korean Journal of Serum Hepatitis B Virus DHA Level and Hepatocellulor Carcinoma

Seong Gyu Hwang

Clin Mol Hepatol. 2006;12(4):583-586. Published online January 1, 1970

View: 2423 Download: 15

3

Clinical Significances of Serum Soluble Fas and Soluble Fas Ligand in Chronic Hepatitis B

Eun Jung Jun, M.D., Joon-Yeol Han, M.D., and Hee Sik Sun, M.D.

Clin Mol Hepatol. 2006;12(4):507-514. Published online January 1, 1970

View: 2745 Download: 21

2

Resistance to Adefovir in Patients with Chronic Hepatitis B

Soo Hyung Ryu, M.D.,* Young-Hwa Chung, M.D.

Clin Mol Hepatol. 2006;12(4):484-492. Published online January 1, 2000

View: 2797 Download: 27

3

Detection of Intrahepatic HBV DNA in HBsAg-negative Liver Diseases

Yun Soo Kim, M.D., Jae Young Jang, M.D. Soo Hoon Eun M.D. Young Koog Cheon, M.D. Young Seok Kim, M.D. Jong Ho Moon, M.D. Young Deok Cho, M.D. So-Young Jin, M.D. Chan Sup Shim, M.D. Boo Sung Kim, M.D.

Clin Mol Hepatol. 2006;12(2):201-208. Published online January 1, 1970

View: 2320 Download: 19

Change of Hepatitis B Virus DNA Status in Anti-HBc Positive Liver Graft

Choon Hyuck Kwon, M.D., Kyung-Suk Suh, M.D., Ph.D., Jai Young Cho, M.D., Nam-Joon Yi, M.D., Ph.D., Ja-June Jang, M.D., Ph.D. and Kuhn Uk Lee, M.D., Ph.D., FACS

Clin Mol Hepatol. 2006;12(2):191-200. Published online January 1, 1970

View: 2803 Download: 23

Comparison of Clinical Outcome Between Patients Continuing and Discontinuing Lamivudine Therapy in Acute Exacerbation After Viral breakthrough During Lamivudine Therapy in Chronic Hepatitis B

Jong Ryul Eun

Clin Mol Hepatol. 2006;12(2):184-190. Published online January 1, 1970

View: 2156 Download: 14

1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |

Viewed By 5505	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5405	MAFLD: How is it different from NAFLD?
Viewed By 5214	Evaluating the therapeutic efficacy of NAD supplementation in management of metabolic dysfunction-associated steatotic liver disease: Key considerations
Viewed By 5094	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 4725	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 176	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 113	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 108	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 90	MAFLD: How is it different from NAFLD?
Cited By 80	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach

Search